197 related articles for article (PubMed ID: 30734335)
1. Treatment outcome in juvenile-onset myasthenia gravis.
Jastrzębska A; Jastrzębski M; Ryniewicz B; Kostera-Pruszczyk A
Muscle Nerve; 2019 May; 59(5):549-554. PubMed ID: 30734335
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of patients with Myasthenia gravis from the Henan province, China.
Gao F; Zhao X; Zhang J; Cui X; Zhang Y; Li Q; Liu P; Fang H; Du Y; Zhang Q; Yang J; Zhang Y
Muscle Nerve; 2016 May; 53(5):711-6. PubMed ID: 26403759
[TBL] [Abstract][Full Text] [Related]
3. Outcome in juvenile-onset myasthenia gravis: a retrospective study with long-term follow-up of 79 patients.
Lindner A; Schalke B; Toyka KV
J Neurol; 1997 Aug; 244(8):515-20. PubMed ID: 9309559
[TBL] [Abstract][Full Text] [Related]
4. The characteristics of juvenile myasthenia gravis among South Africans.
Heckmann JM; Hansen P; Van Toorn R; Lubbe E; Janse van Rensburg E; Wilmshurst JM
S Afr Med J; 2012 May; 102(6):532-6. PubMed ID: 22668957
[TBL] [Abstract][Full Text] [Related]
5. Serum Acetylcholine Receptor Antibodies Before the Clinical Onset of Myasthenia Gravis.
Strijbos E; Verschuuren JJGM; Kuks JBM
J Neuromuscul Dis; 2018; 5(2):261-264. PubMed ID: 29865092
[TBL] [Abstract][Full Text] [Related]
6. Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study.
Chou CC; Su IC; Chou IJ; Lin JJ; Lan SY; Wang YS; Kong SS; Chen YJ; Hsieh MY; Hung PC; Wang HS; Chou ML; Lin KL;
BMC Neurol; 2019 Jul; 19(1):170. PubMed ID: 31319795
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of thymectomy in myasthenia gravis patients with thymus hyperplasia.
Yang J; Liu C; Li T; Li C
Int J Neurosci; 2017 Sep; 127(9):785-789. PubMed ID: 27819773
[TBL] [Abstract][Full Text] [Related]
8. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
Saulat B; Maertens P; Hamilton WJ; Bassam BA
Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
[No Abstract] [Full Text] [Related]
9. Outcome after Robotic-Assisted Thymectomy in Children and Adolescents with Acetylcholine Receptor Antibody-Positive Juvenile Myasthenia Gravis.
Della Marina A; Kölbel H; Müllers M; Kaiser O; Ismail M; Swierzy M; Rueckert JC; Schara U
Neuropediatrics; 2017 Aug; 48(4):315-322. PubMed ID: 28628938
[No Abstract] [Full Text] [Related]
10. Intravenous immune globulin in myasthenia gravis.
Gajdos P
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
[TBL] [Abstract][Full Text] [Related]
11. Juvenile myasthenia gravis: treatment with immune globulin and thymectomy.
Herrmann DN; Carney PR; Wald JJ
Pediatr Neurol; 1998 Jan; 18(1):63-6. PubMed ID: 9492094
[TBL] [Abstract][Full Text] [Related]
12. Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.
Pasnoor M; Wolfe GI; Nations S; Trivedi J; Barohn RJ; Herbelin L; McVey A; Dimachkie M; Kissel J; Walsh R; Amato A; Mozaffar T; Hungs M; Chui L; Goldstein J; Novella S; Burns T; Phillips L; Claussen G; Young A; Bertorini T; Oh S
Muscle Nerve; 2010 Mar; 41(3):370-4. PubMed ID: 19882635
[TBL] [Abstract][Full Text] [Related]
13. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
Oosterhuis HJ
Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
[No Abstract] [Full Text] [Related]
14. Juvenile myasthenia gravis in Norway: Clinical characteristics, treatment, and long-term outcome in a nationwide population-based cohort.
Popperud TH; Boldingh MI; Rasmussen M; Kerty E
Eur J Paediatr Neurol; 2017 Sep; 21(5):707-714. PubMed ID: 28457757
[TBL] [Abstract][Full Text] [Related]
15. Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis.
Clifford KM; Hobson-Webb LD; Benatar M; Burns TM; Barnett C; Silvestri NJ; Howard JF; Visser A; Crum BA; Nowak R; Beekman R; Kumar A; Ruzhansky K; Chen IA; Pulley MT; Laboy SM; Fellman MA; Howard DB; Kolb NA; Greene SM; Pasnoor M; Dimachkie MM; Barohn RJ; Hehir MK
Muscle Nerve; 2019 Apr; 59(4):404-410. PubMed ID: 30575980
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary treatment for prepubertal juvenile myasthenia gravis with crisis.
Hirata Y; Inoue M; Nabatame S; Okumura M; Ozono K
Pediatr Int; 2016 Aug; 58(8):772-4. PubMed ID: 27324449
[TBL] [Abstract][Full Text] [Related]
17. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
O'carroll P; Bertorini TE; Jacob G; Mitchell CW; Graff J
J Clin Neuromuscul Dis; 2009 Dec; 11(2):69-71. PubMed ID: 19955986
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and evolution of juvenile myasthenia gravis in a French cohort.
Barraud C; Desguerre I; Barnerias C; Gitiaux C; Boulay C; Chabrol B
Muscle Nerve; 2018 Apr; 57(4):603-609. PubMed ID: 28877546
[TBL] [Abstract][Full Text] [Related]
19. Prior damage to lower motor neuron triggering myasthenia gravis.
Steiner I; Goldstein L; Hellmann MA; Lotan I
Muscle Nerve; 2016 Jun; 54(1):167-9. PubMed ID: 26789735
[No Abstract] [Full Text] [Related]
20. Maintenance IVIg therapy in myasthenia gravis does not affect disease activity.
Hellmann MA; Mosberg-Galili R; Lotan I; Steiner I
J Neurol Sci; 2014 Mar; 338(1-2):39-42. PubMed ID: 24267740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
